Print PDF

Practice Areas

DEA Intends to Restrict Imports and Exports of Three Synthetic Cannabinoids

Friday, December 19, 2014
Sandler, Travis & Rosenberg Trade Report

The Drug Enforcement Administration has announced its intent to temporarily include three synthetic cannabinoids into Schedule I of the Controlled Substances Act. Synthetic cannabinoids are chemicals synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol, the main psychoactive ingredient in marijuana. The specific substances targeted under this action are:

-    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (common name AB-CHMINACA);

-    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (common name AB-PINACA); and

-    [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (common name THJ-2201).

The DEA notes that this action is based on a finding that the placement of these synthetic cannabinoids into Schedule I is necessary to avoid an imminent hazard to the public safety. Any final order, which the DEA states will be issued as soon as possible after the expiration of a 30-day layover period, will impose the administrative, civil and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research and conduct of instructional activities of these synthetic cannabinoids. 

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines